Insider Activity of Hoitt Jason
According to the SEC Form 4 filings, Hoitt Jason, being in a position of
- Chief Patient Officer at Stoke Therapeutics, Inc.,оver the last 12 months, has bought 0 shares, and sold 3712 shares for $119,311,over all time since 2026-03-17, has bought 0 shares, and sold 3712 shares for $119,311.
Biography of Hoitt Jason
No biography is available at this moment.